Fabian Gerlinghaus | Source | CEO and Co-founder at Cellares

Fabian Gerlinghaus is Co-Founder and Chief Executive Officer of Cellares, a San Francisco, California-based biotechnology and cell therapy startup working on cell therapy solutions.

Fabian is driven by a strong sense of purpose and is passionate about building the future of cell therapy manufacturing. With 10+ years of experience as an innovator and a leader, Fabian has established a track record of assembling top-performing teams to successfully drive novel bioprocessing technologies from ideation to commercial readiness.

Fabian alongside Omar Kurdi and Alex Perch started the company in 2019 and have raised more than $100-million in less than two years
The company grew from the three founders, to a team of more than 50 employees and expects to grow further to more than 150 by the end of 2022
Prior to Cellares, Mr. Gerlinghaus served as chief innovation officer at Synthego, where he co-invented the company’s proprietary RNA synthesizer technology and took this device from whiteboard sketch to a production-ready instrument within two years, enabling the company to be the first to market with its CRISPR/Cas9 product portfolio
He earned a master’s degree in aerospace engineering from the Technical University of Munich, and an honors degree in technology management from the Center for Digital Technology and Management, Munich and made the switch to biotech eight years ago.